The mounting popularity of GLP-1 therapies is changing how people – and the healthcare system – address type 2 diabetes and obesity care. This distinguished panel of clinical leaders will share what they believe must be contemplated when healthcare leaders are making precise benefit decisions, despite having no historical parallel to the situation we currently face with GLP-1s. Speakers: Shealynn Buck, MD - Chief Medical Officer, Lockton Robert Gabbay, MD, PhD, FACP - Chief Scientific and Medical Officer, American Diabetes Association Timothy Law, DO, MBA - Chief Medical Officer, Highmark Health Vidya Raman-Tangella - Chief Medical Officer, Teladoc Health

Related Videos :







Understanding the New Breakthroughs in Weight Loss and Diabetes Care [VH1Z7NVub]

Understanding the New Breakthroughs in Weight Loss and Diabetes Care [VH1Z7NVub]

The mounting popularity of GLP-1 therapies is changing how people – and the healthcare system – address type 2 diabetes and obesity care. This distinguished panel of clinical leaders will share what they believe must be contemplated when healthcare leaders are making precise benefit decisions, despite having no historical parallel to the situation we currently face with GLP-1s. Speakers: Shealynn Buck, MD - Chief Medical Officer, Lockton Robert Gabbay, MD, PhD, FACP - Chief Scientific and Medical Officer, American Diabetes Association Timothy Law, DO, MBA - Chief Medical Officer, Highmark Health Vidya Raman-Tangella - Chief Medical Officer, Teladoc Health

Related Videos :

Aired: December 3rd 2024

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now